447 related articles for article (PubMed ID: 28488390)
1. Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner.
Gazdic M; Simovic Markovic B; Vucicevic L; Nikolic T; Djonov V; Arsenijevic N; Trajkovic V; Lukic ML; Volarevic V
J Tissue Eng Regen Med; 2018 Feb; 12(2):e1173-e1185. PubMed ID: 28488390
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells.
Milosavljevic N; Gazdic M; Simovic Markovic B; Arsenijevic A; Nurkovic J; Dolicanin Z; Djonov V; Lukic ML; Volarevic V
Liver Transpl; 2017 Aug; 23(8):1040-1050. PubMed ID: 28481005
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between mesenchymal stem cells and T regulatory cells is crucially important for the attenuation of acute liver injury.
Gazdic M; Markovic BS; Arsenijevic A; Jovicic N; Acovic A; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML; Volarevic V
Liver Transpl; 2018 May; 24(5):687-702. PubMed ID: 29500914
[TBL] [Abstract][Full Text] [Related]
4. A critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide.
Cao Z; Dhupar R; Cai C; Li P; Billiar TR; Geller DA
J Immunol; 2010 Aug; 185(4):2536-43. PubMed ID: 20624945
[TBL] [Abstract][Full Text] [Related]
5. Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro.
Inui T; Nakagawa R; Ohkura S; Habu Y; Koike Y; Motoki K; Kuranaga N; Fukasawa M; Shinomiya N; Seki S
J Immunol; 2002 Dec; 169(11):6127-32. PubMed ID: 12444115
[TBL] [Abstract][Full Text] [Related]
6. Alpha-galactosylceramide modulates the induction of indoleamine 2,3-dioxygenase in antigen presenting cells.
Fallarini S; Paoletti T; Panza L; Lombardi G
Biochem Pharmacol; 2008 Sep; 76(6):738-50. PubMed ID: 18671950
[TBL] [Abstract][Full Text] [Related]
7. Ability of IDO to attenuate liver injury in alpha-galactosylceramide-induced hepatitis model.
Ito H; Hoshi M; Ohtaki H; Taguchi A; Ando K; Ishikawa T; Osawa Y; Hara A; Moriwaki H; Saito K; Seishima M
J Immunol; 2010 Oct; 185(8):4554-60. PubMed ID: 20844202
[TBL] [Abstract][Full Text] [Related]
8. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells.
Biburger M; Tiegs G
J Immunol; 2005 Aug; 175(3):1540-50. PubMed ID: 16034092
[TBL] [Abstract][Full Text] [Related]
9. Natural killer T cell activation increases iNOS
Paul S; Chhatar S; Mishra A; Lal G
J Immunother Cancer; 2019 Aug; 7(1):208. PubMed ID: 31387637
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
[TBL] [Abstract][Full Text] [Related]
11. Natural killer T cell ligand alpha-galactosylceramide protects against gut ischemia reperfusion-induced organ injury in mice.
Zhang J; Bi J; Ren Y; Du Z; Li T; Li Q; Ke M; Dong J; Lv Y; Wu R
Cytokine; 2018 Nov; 111():237-245. PubMed ID: 30195979
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.
Nakagawa R; Nagafune I; Tazunoki Y; Ehara H; Tomura H; Iijima R; Motoki K; Kamishohara M; Seki S
J Immunol; 2001 Jun; 166(11):6578-84. PubMed ID: 11359810
[TBL] [Abstract][Full Text] [Related]
13. Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor.
Cao Z; Yuan Y; Jeyabalan G; Du Q; Tsung A; Geller DA; Billiar TR
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G249-58. PubMed ID: 19556359
[TBL] [Abstract][Full Text] [Related]
14. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS
J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088
[TBL] [Abstract][Full Text] [Related]
15. Interaction between LPS-induced NO production and IDO activity in mouse peritoneal cells in the presence of activated Valpha14 NKT cells.
Ohtaki H; Ito H; Ando K; Ishikawa T; Hoshi M; Tanaka R; Osawa Y; Yokochi T; Moriwaki H; Saito K; Seishima M
Biochem Biophys Res Commun; 2009 Nov; 389(2):229-34. PubMed ID: 19715679
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid alleviates Con A-induced hepatitis and differentially regulates effector production in NKT cells.
Lee KA; Song YC; Kim GY; Choi G; Lee YS; Lee JM; Kang CY
Eur J Immunol; 2012 Jul; 42(7):1685-94. PubMed ID: 22585464
[TBL] [Abstract][Full Text] [Related]
17. Mice deficient in Vbeta8+NKT cells are resistant to experimental hepatitis but are partially susceptible to generalised Shwartzman reaction.
Habu Y; Shinomiya N; Kinoshita M; Matsumoto A; Kawabata T; Seki S
Clin Exp Med; 2007 Mar; 7(1):30-8. PubMed ID: 17380303
[TBL] [Abstract][Full Text] [Related]
18. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.
Ren G; Su J; Zhang L; Zhao X; Ling W; L'huillie A; Zhang J; Lu Y; Roberts AI; Ji W; Zhang H; Rabson AB; Shi Y
Stem Cells; 2009 Aug; 27(8):1954-62. PubMed ID: 19544427
[TBL] [Abstract][Full Text] [Related]
19. A murine model of NKT cell-mediated liver injury induced by alpha-galactosylceramide/d-galactosamine.
Fujii H; Seki S; Kobayashi S; Kitada T; Kawakita N; Adachi K; Tsutsui H; Nakanishi K; Fujiwara H; Ikarashi Y; Taniguchi M; Kronenberg M; Ikemoto M; Nakajima Y; Arakawa T; Kaneda K
Virchows Arch; 2005 Jun; 446(6):663-73. PubMed ID: 15906084
[TBL] [Abstract][Full Text] [Related]
20. Valpha14 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes.
Ohtaki H; Ito H; Ando K; Ishikawa T; Saito K; Imawari M; Yokochi T; Moriwaki H; Seishima M
Biochem Biophys Res Commun; 2009 Jan; 378(3):579-83. PubMed ID: 19056341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
